Financials

  • Market Capitalization 464.58 M
  • Employee 116
  • Founded 2013
  • CEO Shankar Musunuri
  • Website www.ocugen.com
  • Headquarter Delaware, United States
  • FIGI BBG00194VJB1
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-5.87
Price to sales ratio
91.83

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2968
DNA
Ginkgo Bioworks Holdings, Inc. Class A Common Stock
7.27 USD+0.41%+1.96%-5.58%-18.13%467.75 M USD
2970
PRTA
Prothena Corporation plc - Ordinary Shares
9.38 USD+3.19%+1.08%+8.56%+13.42%481.54 M USD
2980
ARCT
Arcturus Therapeutics Holdings Inc. - Common Stock
15.24 USD-5.75%+25.54%+165.04%-10.51%433.17 M USD
2990
CMPX
Compass Therapeutics, Inc. - Common Stock
2.50 USD-0.79%+3.31%+23.15%-28.16%450.22 M USD

Frequently asked questions about Ocugen, Inc. Common Stock

What is the Ocugen, Inc. Common Stock stock price today?

The current price of Ocugen, Inc. Common Stock (OCGN) is 1.37. Over the past 24 hours, the stock has changed by -2.84%. Follow the OCGN chart for real-time price dynamics.

What is the stock ticker of Ocugen, Inc. Common Stock?

Ocugen, Inc. Common Stock trades under the ticker OCGN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Ocugen, Inc. Common Stock stock going up?

OCGN has changed by -2.84% over the last week, +9.60% over the last month, and +31.73% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Ocugen, Inc. Common Stock?

Ocugen, Inc. Common Stock currently has a market capitalization of 464.58 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Ocugen, Inc. Common Stock earnings last quarter?

Last quarter, Ocugen, Inc. Common Stock reported earnings of -0.07 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Ocugen, Inc. Common Stock revenue for the last quarter?

Ocugen, Inc. Common Stock reported quarterly revenue of 1.49 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Ocugen, Inc. Common Stock net income for the last quarter?

Ocugen, Inc. Common Stock reported net income of -24.88 M for the last quarter. The previous quarter showed -19.18 M, which means net income changed by -29.72%.

How many employees does Ocugen, Inc. Common Stock have?

As of the latest available data, Ocugen, Inc. Common Stock has 116 employees. Workforce size can provide additional context about the company's scale and operations.

What is Ocugen, Inc. Common Stock EBITDA?

Ocugen, Inc. Common Stock EBITDA is -14.99 M, and its EBITDA margin is -1 007.59%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Ocugen, Inc. Common Stock stock?

You can buy Ocugen, Inc. Common Stock (OCGN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Ocugen, Inc. Common Stock stock?

Investing in Ocugen, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the OCGN chart and related analysis on metatrader.com as part of your research.

News